Alpha Tau Medical Ltd.
NASDAQ:DRTS
2.2 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kosten van de omzet
| 0 | 0 | 1.074 | 0 | 0.512 | 0 | 0.979 | 0 | 0 | 0.231 | 0.776 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinst
| 0 | 0 | -1.074 | 0 | -0.512 | 0 | -0.979 | 0 | 0 | -0.231 | -0.776 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Onderzoek- en ontwikkelingskosten
| 6.866 | 6.448 | 7.49 | 6.673 | 5.955 | 6.306 | 5.38 | 4.827 | 5.448 | 5.235 | 3.229 | 3.032 | 2.997 | 2.189 | 2.677 | 2.677 | 1.534 | 1.534 | 1.659 | 1.659 | 1.659 | 1.659 |
Algemene en administratieve kosten
| 1.588 | 1.443 | 2.001 | 1.7 | 1.693 | 1.938 | 2.208 | 2.283 | 2.443 | 3.338 | 0.588 | 0.5 | 0.394 | 0.379 | 0.403 | 0.403 | 0.304 | 0.304 | 0.344 | 0.344 | 0.344 | 0.344 |
Verkoop- en marketingkosten
| 0.6 | 0.533 | 0.452 | 0.552 | 0.52 | 0.4 | 0.397 | 0.248 | 0.121 | 0.208 | 0.126 | 0.102 | 0.087 | 0.167 | 0.073 | 0.073 | 0.072 | 0.072 | 0.099 | 0.099 | 0.099 | 0.099 |
Verkoop-, algemene en administratieve kosten
| 2.188 | 1.976 | 1.379 | 2.252 | 2.213 | 2.338 | 2.605 | 2.531 | 2.564 | 3.546 | 0.714 | 0.602 | 0.481 | 0.546 | 0.475 | 0.475 | 0.375 | 0.375 | 0.443 | 0.443 | 0.443 | 0.443 |
Overige kosten
| 0 | 6.448 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.694 | -4.694 | -4.694 | -4.694 | -4.104 | -4.104 | -4.104 | -4.104 |
Bedrijfskosten
| 9.054 | 8.424 | 8.869 | 8.925 | 8.168 | 8.644 | 7.985 | 7.358 | 8.012 | 8.781 | 3.943 | 3.634 | 3.478 | 2.735 | 2.557 | 2.557 | 2.112 | 2.112 | -2.003 | -2.003 | -2.003 | -2.003 |
Bedrijfsresultaat
| -9.054 | -8.424 | -9.943 | -8.925 | -8.168 | -8.644 | -7.985 | -7.358 | -8.012 | -8.781 | -3.943 | -3.634 | -3.478 | -2.735 | -2.713 | -2.713 | -1.909 | -1.909 | -2.003 | -2.003 | -2.003 | -2.003 |
Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Totaal overige inkomsten en kosten netto
| 1.688 | 0.444 | 2.586 | 3.974 | -0.499 | 0.478 | 4.592 | 4.744 | 6.019 | -16.961 | 0.148 | -1.168 | -3.489 | -8.965 | 0.298 | 0.298 | -0.038 | -0.038 | -0.077 | -0.077 | -0.077 | -0.077 |
Inkomen voor belasting
| -7.366 | -7.98 | -7.357 | -4.951 | -8.667 | -8.166 | -3.393 | -2.614 | -1.993 | -25.742 | -3.795 | -4.802 | -6.967 | -11.7 | -2.415 | -2.415 | -1.947 | -1.947 | -2.08 | -2.08 | -2.08 | -2.08 |
Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Belastingkosten
| 0.003 | 0.001 | 0.008 | -0.039 | 0.026 | 0.021 | 0.003 | 0.009 | 0.006 | 0.002 | -0.014 | -0.005 | 0.015 | 0.011 | 0.007 | 0.007 | 0.073 | 0.073 | 0.037 | 0.037 | 0.037 | 0.037 |
Nettowinst
| -7.369 | -7.981 | -7.365 | -4.912 | -8.693 | -8.187 | -3.396 | -2.623 | -1.999 | -25.744 | -3.781 | -4.797 | -6.982 | -11.711 | -2.422 | -2.422 | -2.02 | -2.02 | -2.116 | -2.116 | -2.116 | -2.116 |
Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
WPA (Winst Per Aandeel)
| -0.11 | -0.11 | -0.11 | -0.071 | -0.13 | -0.12 | -0.049 | -0.038 | -0.029 | -0.54 | -0.08 | -0.071 | -0.1 | -0.17 | -0.063 | -0.063 | -0.048 | -0.048 | -0.031 | -0.031 | -0.031 | -0.031 |
Verwaterde WPA
| -0.11 | -0.11 | -0.11 | -0.071 | -0.13 | -0.12 | -0.049 | -0.038 | -0.029 | -0.54 | -0.08 | -0.071 | -0.1 | -0.17 | -0.063 | -0.063 | -0.048 | -0.048 | -0.031 | -0.031 | -0.031 | -0.031 |
EBITDA
| -8.774 | -8.156 | -8.869 | -8.68 | -8.155 | -8.399 | -2.414 | -7.114 | -7.768 | -8.55 | 0.685 | -3.445 | -3.289 | -2.571 | -2.689 | -2.689 | -1.89 | -1.89 | -2.055 | -2.055 | -2.055 | -2.055 |
EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |